Reversal of Alopecia Universalis by Tofacitinib: A Case Report

    November 2016 in “ Annals of Internal Medicine
    Morton Scheinberg, Sineida Berbert Ferreira
    Image of study
    TLDR Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.
    The document from 2016 reported on the use of tofacitinib citrate, a drug approved for rheumatoid arthritis, in treating alopecia universalis. It described two cases where patients experienced progressive hair growth after prolonged administration of tofacitinib, with no adverse events noted after 9 months. Despite these positive outcomes, the authors warned of potential serious side effects from long-term use of Janus kinase inhibitors and called for clinical trials to assess the treatment's efficacy and safety for alopecia universalis. The exact number of participants was not provided.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 6 results

    Related Research

    8 / 8 results